Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...

A top European court says the European Commission was wrong to refuse the New York Times access to text messages sent between ...

The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

China said on Wednesday it would further enhance capital market support for science and technology innovation enterprises and ...

After 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...

A case against one of the major COVID-19 vaccine providers filed by the Kansas Attorney General will be heard at the state ...

Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...